EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Effect of α -Lipoic Acid on Oxidative Stress in End-Stage Renal Disease Patients Receiving Intravenous Iron

Arif Showkat, William R Bastnagel, Joanna Q Hudson

ISRN Nephrology · 2014

DOI: 10.1155/2014/634515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Nephrology, 2014. Verfasst von Arif Showkat und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, 956 Court Avenue, Suite B224, Memphis, TN 38163, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: American College of Clinical Pharmacy Research Institute.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress is associated with increased risk of cardiovascular disease in end-stage renal disease (ESRD) patients. Intravenous (IV) iron has been shown to increase oxidative stress. The aim of the study was to evaluate changes in oxidative stress markers following administration of IV sodium ferric gluconate (SFG) to ESRD patients with and without administration of the antioxidant, α -lipoic acid. This is an open-label, crossover study. 125 mg of IV SFG was administered during control (C) and intervention (I) visits. During the I visit, 600 mg of α -lipoic acid was given orally prior to IV SFG. Blood samples were collected at defined time periods for F 2 -isoprostane (FIP), lipid hydroperoxide (LHP), malondialdehyde (MDA), and iron indices. We recruited ten African-American ESRD subjects: 50% male; mean age 45 ± 9 years; mean hemoglobin 13 ± 1 g/dL; ferritin 449 ± 145 ng/mL; transferrin saturation 27 ± 4 %. There were no significant differences in iron indices between the two visits after IV SFG. MDA, FIP, and LHP increased significantly for both C and I visits with a greater increase in the I group. Administration of IV SFG results in an acute rise in oxidative stress in ESRD patients. In contrast to previous studies, administration of α -lipoic acid was associated with a greater increase in oxidative stress.

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, 956 Court Avenue, Suite B224, Memphis, TN 38163, USA.
  • Emergency Department, Methodist Affiliated Hospitals, Memphis, TN 38163, USA.
  • Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, 956 Court Avenue, Suite B224, Memphis, TN 38163, USA ; Department of Clinical Pharmacy, University of Tennessee Health Scien…

Förderung

  • American College of Clinical Pharmacy Research Institute

Zitieren

APA

Showkat, A., Bastnagel, W. R., & Hudson, J. Q. (2014). Effect of α -Lipoic Acid on Oxidative Stress in End-Stage Renal Disease Patients Receiving Intravenous Iron. ISRN Nephrology. https://doi.org/10.1155/2014/634515

Vancouver

Showkat A, Bastnagel WR, Hudson JQ. Effect of α -Lipoic Acid on Oxidative Stress in End-Stage Renal Disease Patients Receiving Intravenous Iron. ISRN Nephrology. 2014. doi:10.1155/2014/634515

BibTeX
@article{Showkat2014,
  author = {Showkat, Arif and Bastnagel, William R and Hudson, Joanna Q},
  title = {Effect of α -Lipoic Acid on Oxidative Stress in End-Stage Renal Disease Patients Receiving Intravenous Iron},
  journal = {ISRN Nephrology},
  year = {2014},
  doi = {10.1155/2014/634515}
}
Kostenlos starten →